MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

When Presynaptic Stimulation is Not Enough: Severe Biphasic Dyskinesia on LECIG Reversed by Postsynaptic Apomorphine Rescue

A. Alonso Cánovas, I. Parees Moreno, C. Moreno Lopez, A. Patiño Paton, EJ. Martinez Esteban, P. Perez Torre, JL. López Sendón, JC. Martinez Castrillo (Madrid, Spain)

Meeting: 2026 International Congress

Keywords: Apomorphine, Dyskinesias, Parkinson’s

Category: Parkinson’s Disease: Pharmacology and Medical Management

Objective: To report an exceptional case of advanced Parkinson’s disease (PD) where levodopa/carbidopa/entacapone intestinal gel (LECIG) failed to provide adequate motor control, ultimately requiring a return to continuous subcutaneous apomorphine infusion (CSAI) to bypass severe presynaptic denervation.

Background: Continuous drug delivery systems, such as LECIG and CSAI, are designed to provide continuous dopaminergic stimulation. However, their efficacy depends on different mechanisms: levodopa requires functional presynaptic terminals for conversion to dopamine, whereas apomorphine acts directly on postsynaptic receptors.

Method: A 75-year-old woman with advanced PD, previously well-controlled on CSAI and oral levodopa, developed generalized subcutaneous nodules, forcing the discontinuation of apomorphine. Transition to oral therapy (levodopa, opicapone, and dopamine agonists) resulted in near-permanent “OFF” states despite multiple adjustments. Consequently, LECIG was initiated.

Results: While the initial nasoduodenal phase was successful (video will be provided), the patient developed a catastrophic clinical picture two weeks after PEG placement: Continuous Biphasic Dyskinesia: The patient experienced unrelenting, severe involuntary movements accompanied by profound psychological distress and anxiety (video will be provided). Failure of High-Dose Levodopa: Despite escalating the LECIG dose to 4 grams of levodopa per day, the “OFF” periods and biphasic transitions could not be resolved. Successful Rescue: Due to the clinical emergency, LECIG was discontinued, and CSAI was reintroduced (8 mg/h 24 h infusion), managing skin sites carefully, alongside oral levodopa (400 mg every 4 h) and opicapone. Follow-up: This combination successfully restored motor stability and resolved the dyskinesias. The improvement has been sustained for over one year.

Conclusion: This case illustrates a critical pharmacological threshold in advanced PD. We hypothesize that the patient’s extreme presynaptic denervation rendered even high-dose continuous levodopa (LECIG) insufficient to cross the therapeutic threshold for stable motor control. In such very advanced cases, direct postsynaptic stimulation via apomorphine may be a viable mechanism to bypass the lack of endogenous levodopa-to-dopamine conversion and storage capacity.

To cite this abstract in AMA style:

A. Alonso Cánovas, I. Parees Moreno, C. Moreno Lopez, A. Patiño Paton, EJ. Martinez Esteban, P. Perez Torre, JL. López Sendón, JC. Martinez Castrillo. When Presynaptic Stimulation is Not Enough: Severe Biphasic Dyskinesia on LECIG Reversed by Postsynaptic Apomorphine Rescue [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/when-presynaptic-stimulation-is-not-enough-severe-biphasic-dyskinesia-on-lecig-reversed-by-postsynaptic-apomorphine-rescue/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/when-presynaptic-stimulation-is-not-enough-severe-biphasic-dyskinesia-on-lecig-reversed-by-postsynaptic-apomorphine-rescue/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley